MichelsonDFavaMAmsterdamJApterJLondborgPTamuraR, and others. Interruption of selective serotonin reuptake inhibitor treatment: Double blind, placebo controlled trial. Br J Psychiatry2000;176:363–8.
4.
Von KanelRDimsdaleJE. Effects of sympathetic activation by adrenergic infusions on hemostasis in vivo. Eur J Haematol2000;65:357–69.
5.
HarkerLARitchieJL. The role of platelets in acute vascular events. Circulation1980;6:8–13.
6.
SauerWHBerlinJAKimmelSE. Effect of antidepressants and their relative affinity for the serotonin transporter on the risk of myocardial infarction. Circulation2003;108:32–6.
7.
RamasubbuRPattenSB. Effect of depression on stroke morbidity and mortality. Can J Psychiatry2003;48:250–7.
8.
SauerWHBerlinJAKimmelSE. Selective serotonin reuptake inhibitors and myocardial infarction. Circulation2001;104:1894–8.
9.
MusselmanDLTomerAManatungaAKKnightBTPorterMRKaseyS, and others. Exaggerated platelet reactivity in major depression. Am J Psychiatry1996;153:1313–7.
10.
VanschoonbeekKFeijgeMAKeurenJFHemerH CoenraadLodderJJHamulyakK, and others. Thrombin-induced hyperactivity of platelets of young stroke patients: Involvement of thrombin receptors in the subject-dependent variability in Ca2+ signal generation. Thromb Haemost2002;88:931–7.
11.
deAbajoFJJickHDerbyLJickSSchmitzS.Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol, 2000;50:43–7.
12.
BakSTsiropoulosIKjaersgaardJOAndersenMMellerupEHallasJ, and others. Selective serotonin reuptake inhibitors and the risk of stroke. A population-based case-control study. Stroke2002;33:1465–73.